Abstract: A method according to an exemplary aspect of the present disclosure includes, among other things, detecting a battery fault of a battery of an electrified vehicle, activating a HVAC system ON, commanding the HVAC system to a fresh air mode, communicating fresh air into a passenger cabin, and expelling battery vent byproducts from the passenger cabin through at least one air extractor vent during key-on or key-off states.

Abstract: A temperature monitoring vehicle charger cord assembly includes a wall plug; a pair of power prongs carried by the wall plug; at least one thermal sensor carried by the wall plug, the at least one thermal sensor adapted to monitor a charging temperature; a battery electric vehicle electrical plug; and a microprocessor electrically interfacing with the power prongs, the at least one thermal sensor and the battery electric vehicle electrical plug. The microprocessor is programmed to perform at least one of terminating electrical current and reducing amperes of electrical current flowing from the pair of power prongs to the battery electric vehicle electrical plug if the charging temperature at least meets a predetermined maximum threshold charging temperature. A temperature monitoring vehicle charging method is also disclosed.

Abstract: An assembly for discharging a battery using an adjustable variable resistor. A battery is connected to the assembly. An operating sequence for the connected battery is selected from a plurality of predetermined operating sequences for different batteries. The predetermined operating sequences are presented as a function of a battery characteristic. The selected operating sequence adjusts the resistor and the battery is discharged using the adjusted resistor.

Abstract: A temperature monitoring vehicle charger cord assembly includes a wall plug; a pair of power prongs carried by the wall plug; at least one thermal sensor carried by the wall plug, the at least one thermal sensor adapted to monitor a charging temperature; a battery electric vehicle electrical plug; and a microprocessor electrically interfacing with the power prongs, the at least one thermal sensor and the battery electric vehicle electrical plug. The microprocessor is programmed to perform at least one of terminating electrical current and reducing amperes of electrical current flowing from the pair of power prongs to the battery electric vehicle electrical plug if the charging temperature at least meets a predetermined maximum threshold charging temperature. A temperature monitoring vehicle charging method is also disclosed.

Abstract: A method according to an exemplary aspect of the present disclosure includes, among other things, detecting a battery fault of a battery of an electrified vehicle, activating a HVAC system ON, commanding the HVAC system to a fresh air mode, communicating fresh air into a passenger cabin, and expelling battery vent byproducts from the passenger cabin through at least one air extractor vent during key-on or key-off states.

Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.

Abstract: This invention provides a method of treating solid tumors which comprises administering an effective amount of a combination of (1) a bioresponse modifier and (2) a chemotherapeutic agent. This invention also provides a method of potentiating the effects of a chemotherapeutic regimen in a mammal in need of treatment with such regimen which comprises administering a bioresponse modifier in addition to a chemotherapeutic regimen.

Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of CCI-779 and interferon alfa (&agr;) in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of CCI-779 and an aromatase inhibitor in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms.

Abstract: This invention provides the use of CCI-779 in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of CCI-779 and an antimetabolite antineoplastic agent in the treatment of neoplasms.

Abstract: This invention provides the use of a combination of an mTOR inhibitor and an antimetabolite antineoplastic agent in the treatment of neoplasms.

Abstract: This invention provides the use of CCl-779 in the treatment of neoplasms.

Abstract: The invention is a method of treating or inhibiting neutropenia, or accelerating neutrophil recovery in a mammal in need thereof, which comprises administering to said mammal an effective amount of a compound having the formula: ##STR1## wherein R.sub.1 and R.sub.2 are each, independently selected from the group consisting of hydrogen, alkyl of 1-6 carbon atoms, optionally substituted benzoyl, ##STR2## or R.sub.1 and R.sub.2 are methylene groups which are taken together to form a 4-7 membered saturated heterocyclic ring;R is hydroxy, 4-morpholinyl, 1H-imidazol-1 -yl, --CH(alkoxy of 1-6 carbon atoms).sub.2, .alpha.-hydroxybenzyl, or optionally substituted phenyl;R.sub.3 is hydrogen or alkyl; R.sub.4 is hydrogen, halogen, alkyl, alkoxy, or trifluoromethyl; R.sub.5 is hydrogen or alkyl; and n=1-3, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to novel ureas and urethanes of Formula I: ##STR1## which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Compounds in the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases, and in the enhancement of immune response.

Abstract: The invention relates to novel ureas and urethanes of Formula I: ##STR1## which stimulate cytokine production and may be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation, or infections. Compounds in the invention or pharmaceutical compositions employing these compounds may be useful in the treatment of cancer, AIDS, aplastic anemia, myelodysplastic syndrome, and infectious diseases, and in the enhancement of immune response.

Abstract: This invention provides the use of a combination of CCI-779 and EKB-569 in the treatment of neoplasms.